CHRISTOPHER SR DAKHIL
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology
- Where
- PRATT, KS
- NPI
- 1972721348
- Received
- $60,615 in 1,114 records, 2019 to 2025 ($59,078 general, $1,536 research)
- As principal investigator
- $54,478 of research payments to others in 14 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 166 | $4,078 |
| 2024 | General payment | 190 | $4,814 |
| 2023 | General payment | 191 | $18,215 |
| 2022 | General payment | 175 | $13,209 |
| 2022 | Research payment | 1 | $1,536 |
| 2021 | General payment | 141 | $6,404 |
| 2020 | General payment | 101 | $6,168 |
| 2019 | General payment | 149 | $6,186 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 25 | $33,147 |
| Food and Beverage | 1,049 | $18,718 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 5 | $2,684 |
| Honoraria | 3 | $1,550 |
| Research payment | 1 | $1,536 |
| Travel and Lodging | 4 | $1,478 |
| Long term medical supply or device loan | 11 | $1,031 |
| Education | 16 | $469 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-12-19 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-12-17 | Novartis Pharmaceuticals Corporation | $13 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-12-10 | Acrotech Biopharma Inc. | $13 | Food and Beverage | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2025 | |
| 2025-12-09 | EMD Serono, Inc. | $16 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-08 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-12-04 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2025 | |
| 2025-12-03 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-02 | AVYXA PHARMA, LLC | $22 | Food and Beverage | In-kind items and services | KYXATA Drug, ONCOLOGY | 2025 | |
| 2025-12-01 | Astellas Pharma US Inc | $14 | Food and Beverage | In-kind items and services | Xtandi Drug, Oncology | 2025 | |
| 2025-11-25 | PFIZER INC. | $18 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-11-25 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | EMRELIS Drug, ONCOLOGY | 2025 | |
| 2025-11-24 | Incyte Corporation | $16 | Food and Beverage | Cash or cash equivalent | MONJUVI Drug, Oncology | 2025 | |
| 2025-11-20 | Novartis Pharmaceuticals Corporation | $20 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-11-17 | E.R. Squibb & Sons, L.L.C. | $7 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-11-17 | E.R. Squibb & Sons, L.L.C. | $6 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-11-13 | Merck Sharp & Dohme LLC | $10 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-11-10 | E.R. Squibb & Sons, L.L.C. | $15 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-11-03 | Novartis Pharmaceuticals Corporation | $32 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-11-03 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-10-28 | GENZYME CORPORATION | $18 | Food and Beverage | In-kind items and services | WAYRILZ Drug, Immunology | 2025 | |
| 2025-10-27 | PFIZER INC. | $24 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-10-23 | E.R. Squibb & Sons, L.L.C. | $9 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-10-22 | Celgene Corporation | $21 | Food and Beverage | Cash or cash equivalent | BREYANZI Biological, Oncology | 2025 | |
| 2025-10-17 | Immunocore Limited | $17 | Food and Beverage | In-kind items and services | KIMMTRAK Drug, Oncology | 2025 | |
| 2025-10-16 | Novartis Pharmaceuticals Corporation | $12 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-10-15 | Novartis Pharmaceuticals Corporation | $11 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-10-14 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-10-09 | EMD Serono, Inc. | $18 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-08 | SERVIER PHARMACEUTICALS LLC | $17 | Food and Beverage | In-kind items and services | Voranigo Drug, Oncology | 2025 | |
| 2025-10-06 | BeOne Medicines USA, Inc. | $16 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-10-06 | Astellas Pharma US Inc | $14 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-10-03 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-03 | Novartis Pharmaceuticals Corporation | $10 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2025 | |
| 2025-10-01 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-09-29 | Eisai Inc. | $17 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-09-24 | SpringWorks Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | OGSIVEO Drug, DESMOID TUMORS | 2025 | |
| 2025-09-22 | Novartis Pharmaceuticals Corporation | $15 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-09-19 | Novartis Pharmaceuticals Corporation | $10 | Food and Beverage | In-kind items and services | LUTATHERA Drug, Oncology | 2025 | |
| 2025-09-18 | GENZYME CORPORATION | $18 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-09-16 | PFIZER INC. | $12 | Food and Beverage | In-kind items and services | ELREXFIO Drug, ONCOLOGY | 2025 | |
| 2025-09-15 | Janssen Biotech, Inc. | $15 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-09-09 | Geron Corporation | $13 | Education | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-09-08 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-09-04 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-09-04 | Novartis Pharmaceuticals Corporation | $22 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-08-28 | Deciphera Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | QINLOCK Drug, ONCOLOGY | 2025 | |
| 2025-08-27 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-08-26 | Daiichi Sankyo Inc. | $22 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-08-25 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-08-21 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-08-13 | Alexion Pharmaceuticals, Inc. | $13 | Food and Beverage | In-kind items and services | ULTOMIRIS Biological, Rare Disease | 2025 | |
| 2025-08-11 | Takeda Pharmaceuticals U.S.A., Inc. | $20 | Food and Beverage | In-kind items and services | ICLUSIG Drug, ONCOLOGY | 2025 | |
| 2025-08-11 | Genentech USA, Inc. | $19 | Food and Beverage | In-kind items and services | Tecentriq Biological, BioOncology | 2025 | |
| 2025-08-11 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-08-11 | E.R. Squibb & Sons, L.L.C. | $1 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-08-10 | Daiichi Sankyo Inc. | $20 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-08-07 | Stemline Therapeutics Inc. | $15 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2025 | |
| 2025-08-06 | PFIZER INC. | $17 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-08-05 | Sumitomo Pharma America, Inc. | $20 | Food and Beverage | In-kind items and services | ORGOVYX Drug, PROSTATE CANCER | 2025 | |
| 2025-08-04 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-08-04 | Merck Sharp & Dohme LLC | $15 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-07-31 | Regeneron Healthcare Solutions, Inc. | $21 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-07-30 | Regeneron Healthcare Solutions, Inc. | $26 | Food and Beverage | In-kind items and services | LYNOZYFIC Biological, HEMATOLOGY AND ONCOLOGY | 2025 | |
| 2025-07-29 | Immunocore Limited | $29 | Food and Beverage | In-kind items and services | KIMMTRAK Drug, Oncology | 2025 | |
| 2025-07-28 | Geron Corporation | $9 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-07-26 | PFIZER INC. | $11 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-07-25 | Novartis Pharmaceuticals Corporation | $21 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-07-24 | Geron Corporation | $780 | Consulting Fee | Cash or cash equivalent | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-07-24 | Amneal Pharmaceuticals LLC | $22 | Food and Beverage | In-kind items and services | PEMRYDI RTU Drug, ONCOLOGY | 2025 | |
| 2025-07-18 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-07-16 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-07-14 | AstraZeneca Pharmaceuticals LP | $17 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-07-10 | Janssen Biotech, Inc. | $17 | Food and Beverage | In-kind items and services | TALVEY Biological, Oncology | 2025 | |
| 2025-07-08 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-07-07 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | EMRELIS Drug, ONCOLOGY | 2025 | |
| 2025-07-07 | Genentech USA, Inc. | $18 | Food and Beverage | In-kind items and services | Venclexta Biological, BioOncology | 2025 | |
| 2025-07-02 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-02 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-07-01 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-06-30 | GlaxoSmithKline, LLC. | $19 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-06-30 | PFIZER INC. | $13 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-06-26 | JAZZ PHARMACEUTICALS INC. | $19 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-06-25 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-06-23 | Astellas Pharma US Inc | $16 | Food and Beverage | In-kind items and services | Padcev Drug, Oncology | 2025 | |
| 2025-06-23 | E.R. Squibb & Sons, L.L.C. | $9 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-06-20 | Gilead Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-06-16 | SpringWorks Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | OGSIVEO Drug, DESMOID TUMORS | 2025 | |
| 2025-06-16 | Geron Corporation | $10 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2025-06-12 | AstraZeneca Pharmaceuticals LP | $18 | Food and Beverage | In-kind items and services | CALQUENCE Drug, Oncology | 2025 | |
| 2025-06-12 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-09 | ADC THERAPEUTICS AMERICA, INC. | $24 | Food and Beverage | Cash or cash equivalent | ZYNLONTA Drug, ONCOLOGY | 2025 | |
| 2025-06-09 | Eisai Inc. | $20 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-06-09 | E.R. Squibb & Sons, L.L.C. | $9 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-06-09 | E.R. Squibb & Sons, L.L.C. | $5 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-06-05 | Tempus AI, Inc | $17 | Food and Beverage | In-kind items and services | XT CDX Device, ONCOLOGY | 2025 | |
| 2025-06-03 | ARRAY BIOPHARMA INC | $15 | Food and Beverage | In-kind items and services | XALKORI Drug, ONCOLOGY | 2025 | |
| 2025-06-02 | SOBI, INC | $17 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-05-21 | Regeneron Healthcare Solutions, Inc. | $27 | Food and Beverage | In-kind items and services | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-05-20 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-19 | GlaxoSmithKline, LLC. | $18 | Food and Beverage | In-kind items and services | OJJAARA Drug, ONCOLOGY | 2025 | |
| 2025-05-15 | Rigel Pharmaceuticals, Inc. | $13 | Food and Beverage | Cash or cash equivalent | TAVALISSE Drug, Hematology | 2025 | |
| 2025-05-14 | Iovance Biotherapeutics, Inc. | $14 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2025 | |
| 2025-05-13 | Celgene Corporation | $15 | Food and Beverage | Cash or cash equivalent | BREYANZI Biological, Oncology | 2025 | |
| 2025-05-12 | Gilead Sciences, Inc. | $18 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-05-10 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | Trodelvy Drug, ONC | 2025 | |
| 2025-05-09 | Daiichi Sankyo Inc. | $11 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-05-07 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-05-06 | ACCORD HEALTHCARE, INC. | $20 | Food and Beverage | In-kind items and services | Camcevi Drug, Urology Oncology – GnRH agonist for treating adults with advanced prostate cancer | 2025 | |
| 2025-05-06 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-05-02 | Astellas Pharma US Inc | $14 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-05-01 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-05-01 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-04-28 | Janssen Biotech, Inc. | $17 | Food and Beverage | In-kind items and services | CARVYKTI Drug, Oncology | 2025 | |
| 2025-04-26 | Daiichi Sankyo Inc. | $18 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-04-22 | RECORDATI_RARE_DISEASES_INC. | $13 | Food and Beverage | In-kind items and services | ENJAYMO Drug, HEMATOLOGY | 2025 | |
| 2025-04-18 | PFIZER INC. | $5 | Food and Beverage | In-kind items and services | IBRANCE Drug, ONCOLOGY | 2025 | |
| 2025-04-16 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-04-16 | E.R. Squibb & Sons, L.L.C. | $9 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-04-15 | Genentech USA, Inc. | $14 | Food and Beverage | In-kind items and services | Itovebi Biological, BioOncology | 2025 | |
| 2025-04-14 | Aveo Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2025 | |
| 2025-04-14 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-04-14 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | OPDUALAG Drug, Oncology | 2025 | |
| 2025-04-11 | PFIZER INC. | $22 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2025 | |
| 2025-04-11 | PFIZER INC. | $5 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-04-10 | Lilly USA, LLC | $23 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-04-09 | Daiichi Sankyo Inc. | $17 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-04-08 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-04-02 | Novartis Pharmaceuticals Corporation | $10 | Food and Beverage | In-kind items and services | Fabhalta Drug, Immunology | 2025 | |
| 2025-03-31 | Stemline Therapeutics Inc. | $17 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2025 | |
| 2025-03-28 | Secura Bio, Inc. | $20 | Food and Beverage | In-kind items and services | COPIKTRA Drug, ORAL ONCOLOGIC | 2025 | |
| 2025-03-25 | Celgene Corporation | $19 | Food and Beverage | Cash or cash equivalent | ABECMA Biological, Oncology | 2025 | |
| 2025-03-24 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-03-18 | E.R. Squibb & Sons, L.L.C. | $6 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-03-13 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-03-10 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-03-05 | Deciphera Pharmaceuticals Inc. | $16 | Food and Beverage | In-kind items and services | QINLOCK Drug, ONCOLOGY | 2025 | |
| 2025-03-05 | Novartis Pharmaceuticals Corporation | $8 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-02-28 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-02-27 | E.R. Squibb & Sons, L.L.C. | $7 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-02-26 | AVYXA PHARMA, LLC | $18 | Food and Beverage | In-kind items and services | AXTLE Drug, ONCOLOGY | 2025 | |
| 2025-02-24 | AstraZeneca Pharmaceuticals LP | $73 | Food and Beverage (7 payments) | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-02-21 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-02-20 | Janssen Biotech, Inc. | $15 | Food and Beverage | In-kind items and services | DARZALEX Biological, Oncology | 2025 | |
| 2025-02-19 | Acrotech Biopharma Inc. | $31 | Food and Beverage | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2025 | |
| 2025-02-18 | Eisai Inc. | $19 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-02-17 | AstraZeneca Pharmaceuticals LP | $14 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-02-17 | ARRAY BIOPHARMA INC | $11 | Food and Beverage | In-kind items and services | LORBRENA Drug, ONCOLOGY | 2025 | |
| 2025-02-17 | PFIZER INC. | $9 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2025 | |
| 2025-02-13 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-02-05 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2025 | |
| 2025-02-05 | Blue Earth Diagnostics | $15 | Food and Beverage | In-kind items and services | POSLUMA Drug, Diagnostic Imaging | 2025 | |
| 2025-02-03 | ARRAY BIOPHARMA INC | $18 | Food and Beverage | In-kind items and services | XALKORI Drug, ONCOLOGY | 2025 | |
| 2025-01-28 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-01-27 | Astellas Pharma US Inc | $20 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2025 | |
| 2025-01-27 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-01-24 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2025 | |
| 2025-01-24 | Novartis Pharmaceuticals Corporation | $12 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2025 | |
| 2025-01-21 | GENZYME CORPORATION | $19 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2025 | |
| 2025-01-20 | TAIHO ONCOLOGY, INC. | $21 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-01-20 | AstraZeneca Pharmaceuticals LP | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-01-15 | Daiichi Sankyo Inc. | $470 | Consulting Fee | Cash or cash equivalent | DATROWAY Drug, ONCOLOGY | 2025 | |
| 2025-01-14 | E.R. Squibb & Sons, L.L.C. | $17 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-01-08 | Immunocore Limited | $13 | Food and Beverage | In-kind items and services | KIMMTRAK Drug, Oncology | 2025 | |
| 2025-01-06 | PharmaEssentia USA Corporation | $19 | Food and Beverage | In-kind items and services | BESREMI Drug, Oncology | 2025 | |
| 2025-01-03 | EMD Serono, Inc. | $19 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2024-12-23 | Takeda Pharmaceuticals U.S.A., Inc. | $16 | Food and Beverage | In-kind items and services | NINLARO Drug, ONCOLOGY | 2024 | |
| 2024-12-23 | Astellas Pharma US Inc | $13 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2024 | |
| 2024-12-20 | Novartis Pharmaceuticals Corporation | $19 | Food and Beverage | In-kind items and services | PLUVICTO Drug, Oncology | 2024 | |
| 2024-12-20 | EMD Serono, Inc. | $7 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-12-19 | Daiichi Sankyo Inc. | $470 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-12-19 | E.R. Squibb & Sons, L.L.C. | $12 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-12-18 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2024 | |
| 2024-12-16 | Aveo Pharmaceuticals, Inc. | $21 | Food and Beverage | In-kind items and services | FOTIVDA Drug, Oncology | 2024 | |
| 2024-12-16 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2024 | |
| 2024-12-16 | PFIZER INC. | $8 | Food and Beverage | In-kind items and services | XTANDI Drug, ONCOLOGY | 2024 | |
| 2024-12-11 | Merck Sharp & Dohme LLC | $10 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-12-09 | E.R. Squibb & Sons, L.L.C. | $18 | Food and Beverage | Cash or cash equivalent | OPDIVO Biological, Oncology | 2024 | |
| 2024-12-06 | SOBI, INC | $13 | Food and Beverage | In-kind items and services | DOPTELET Drug, HEMATOLOGY/ONCOLOGY | 2024 | |
| 2024-11-26 | Iovance Biotherapeutics, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Amtagvi Drug, Oncology | 2024 | |
| 2024-11-25 | Celgene Corporation | $17 | Food and Beverage | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2024 | |
| 2024-11-23 | Astellas Pharma US Inc | $16 | Food and Beverage | In-kind items and services | Vyloy Drug, Oncology | 2024 | |
| 2024-11-22 | Gilead Sciences, Inc. | $7 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-21 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | Itovebi Biological, BioOncology | 2024 | |
| 2024-11-20 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-11-18 | Gilead Sciences, Inc. | $12 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-18 | EMD Serono, Inc. | $6 | Food and Beverage | Cash or cash equivalent | 2024 | ||
| 2024-11-11 | SUN PHARMACEUTICAL INDUSTRIES INC. | $18 | Food and Beverage | In-kind items and services | YONSA Drug, Oncology | 2024 | |
| 2024-11-06 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VENCLEXTA Drug, ONCOLOGY | 2024 | |
| 2024-11-04 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-11-04 | E.R. Squibb & Sons, L.L.C. | $7 | Food and Beverage | Cash or cash equivalent | KRAZATI Drug, Oncology | 2024 | |
| 2024-11-01 | PFIZER INC. | $15 | Food and Beverage | In-kind items and services | BOSULIF Drug, METABOLIC DISEASE;ONCOLOGY | 2024 | |
| 2024-11-01 | Blue Earth Diagnostics | $14 | Food and Beverage | In-kind items and services | POSLUMA Drug, Diagnostic Imaging | 2024 | |
| 2024-10-29 | Acrotech Biopharma Inc. | $22 | Food and Beverage | In-kind items and services | BELEODAQ Drug, ONCOLOGY | 2024 | |
| 2024-10-29 | KYOWA KIRIN, INC. | $19 | Food and Beverage | In-kind items and services | Poteligeo Drug, Monoclonal Antibody | 2024 | |
| 2024-10-28 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | EPKINLY Drug, ONCOLOGY | 2024 | |
| 2024-10-24 | BeiGene USA, Inc. | $23 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2024 | |
| 2024-10-24 | Amneal Pharmaceuticals LLC | $13 | Food and Beverage | In-kind items and services | AVASTIN Drug, ONCOLOGY | 2024 | |
| 2024-10-22 | GENZYME CORPORATION | $13 | Food and Beverage | In-kind items and services | SARCLISA Biological, Oncology | 2024 | |
| 2024-10-21 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | IMBRUVICA Drug, ONCOLOGY | 2024 |
The latest 200 records of 1,114.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2022-09-19 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $3,500 | PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDO | 2022 |
| 2022-08-22 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $1,275 | PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDO | 2022 |
| 2022-08-22 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $1,275 | PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDO | 2022 |
| 2022-06-21 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $2,477 | A PHASE 2 STUDY OF CONTINUOUS TALAZOPARIB PLUS INTERMITTENT LOWDOSE TEMOZOLOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY | 2022 |
| 2022-02-01 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $7,080 | A PHASE 2 STUDY OF CONTINUOUS TALAZOPARIB PLUS INTERMITTENT LOWDOSE TEMOZOLOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY | 2022 |
| 2021-10-27 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $4,600 | PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDO | 2021 |
| 2019-06-12 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $4,600 | PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDO | 2019 |
| 2019-05-22 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $7,565 | PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDO | 2019 |
| 2019-04-12 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $7,565 | PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDO | 2019 |
| 2019-04-12 | PFIZER INC. | CANCER CENTER OF KANSAS PA | $7,565 | PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDO | 2019 |
| 2019-04-10 | PFIZER INC. | US ONCOLOGY RESEARCH LLC | $1,061 | ARCHER 1042 A PHASE 2 STUDY OF DACOMITINIB IN ADVANCED NONSMALL CELL LUNG CANCER POSTCHEMOTHERAPY OR SELECT FIRST LINE | 2019 |
| 2019-04-03 | PFIZER INC. | US ONCOLOGY RESEARCH LLC | $1,950 | ARCHER 1042 A PHASE 2 STUDY OF DACOMITINIB IN ADVANCED NONSMALL CELL LUNG CANCER POSTCHEMOTHERAPY OR SELECT FIRST LINE | 2019 |
| 2019-04-03 | PFIZER INC. | US ONCOLOGY RESEARCH LLC | $65 | ARCHER 1042 A PHASE 2 STUDY OF DACOMITINIB IN ADVANCED NONSMALL CELL LUNG CANCER POSTCHEMOTHERAPY OR SELECT FIRST LINE | 2019 |
| 2019-04-03 | PFIZER INC. | US ONCOLOGY RESEARCH LLC | $3,900 | ARCHER 1042 A PHASE 2 STUDY OF DACOMITINIB IN ADVANCED NONSMALL CELL LUNG CANCER POSTCHEMOTHERAPY OR SELECT FIRST LINE | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Pratt, KS, county Pratt County, KS, state Kansas; placed by its city name.
| Measure | Place (city or town) Pratt, KS | County Pratt County, KS | State Kansas |
|---|---|---|---|
| Population B01003 | 6,577 | 9,127 | 2,947,197 |
| Population, 2020 census P1 | 6,603 | 9,157 | 2,937,880 |
| Median age B01002 | 36.7 | 38.8 | 37.4 |
| Under 18 B01001 | 23.3% | 24.7% | 23.8% |
| 65 and over B01001 | 19.4% | 21.1% | 17.0% |
| Households B11001 | 2,463 | 3,468 | 1,174,060 |
| Foreign born B05002 | 3.1% | 2.7% | 7.4% |
| Median household income B19013 | $63,819 | $66,022 | $74,275 |
| Median family income B19113 | $71,928 | $79,450 | $95,810 |
| Per capita income B19301 | $29,181 | $32,569 | $40,978 |
| Poverty rate B17001 | 14.3% | 12.3% | 11.3% |
| Unemployment rate B23025 | 3.7% | 3.6% | 3.9% |
| Civilian labor force B23025 | 3,244 | 4,337 | 1,519,375 |
| Mean commute (minutes) B08013 | 10.6 | 12.2 | 19.7 |
| Bachelor's degree or higher B15003 | 22.8% | 25.8% | 35.6% |
| Housing units B25001 | 3,099 | 4,364 | 1,293,635 |
| Owner-occupied B25003 | 69.7% | 73.2% | 67.2% |
| Renters B25003 | 30.3% | 26.8% | 32.8% |
| Median home value B25077 | $107,500 | $114,600 | $217,200 |
| Median gross rent B25064 | $798 | $802 | $1,060 |
| White, not Hispanic B03002 | 81.6% | 84.1% | 72.7% |
| Black B03002 | 0.8% | 0.6% | 5.2% |
| Hispanic or Latino B03002 | 9.9% | 8.6% | 13.6% |
| Asian B03002 | 0.3% | 0.2% | 2.9% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.4% |
Economy now FRED unemployment 3.8% in Sep 2026 (3.8% a year earlier); per capita personal income $69,149 in 2025, up 25% in five years (+0.7% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Pratt, KS.
Comments